P1239: BRUTON TYROSINE KINASE (BTK) PROTEIN DEGRADER BGB-16673 IS LESS APT TO CAUSE, AND ABLE TO OVERCOME VARIABLE BTK RESISTANCE MUTATIONS COMPARED TO OTHER BTK INHIBITORS (BTKI)

• Xiaoyu Feng,
• Yangyang Wang,
• Tao Long,
• Lanyue Bai,
• Xiaojiao Yang,
• Ailing Yang,
• Xiangmei Chen,
• Oscar Puig,
• Yangbo Yue,
• Zhirong Shen

Affiliations

Xiaoyu Feng

1 Translational Discovery, Research and Medicine, BeiGene (Beijing) Co., Ltd, Beijing 100020, China

Yangyang Wang

1 Translational Discovery, Research and Medicine, BeiGene (Beijing) Co., Ltd, Beijing 100020, China

Tao Long

1 Translational Discovery, Research and Medicine, BeiGene (Beijing) Co., Ltd, Beijing 100020, China

Lanyue Bai

1 Translational Discovery, Research and Medicine, BeiGene (Beijing) Co., Ltd, Beijing 100020, China

Xiaojiao Yang

1 Translational Discovery, Research and Medicine, BeiGene (Beijing) Co., Ltd, Beijing 100020, China

Ailing Yang

1 Translational Discovery, Research and Medicine, BeiGene (Beijing) Co., Ltd, Beijing 100020, China

Xiangmei Chen

1 Translational Discovery, Research and Medicine, BeiGene (Beijing) Co., Ltd, Beijing 100020, China

Oscar Puig

1 Translational Discovery, Research and Medicine, BeiGene (Beijing) Co., Ltd, Beijing 100020, China

Yangbo Yue

1 Translational Discovery, Research and Medicine, BeiGene (Beijing) Co., Ltd, Beijing 100020, China

Zhirong Shen

1 Translational Discovery, Research and Medicine, BeiGene (Beijing) Co., Ltd, Beijing 100020, China